374119-30-9Relevant articles and documents
N-Arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B
Greenspan, Paul D.,Clark, Kirk L.,Cowen, Scott D.,McQuire, Leslie W.,Tommasi, Ruben A.,Farley, David L.,Quadros, Elizabeth,Coppa, David E.,Du, Zengming,Fang, Zheng,Zhou, Huanghai,Doughty, John,Toscano, Karen T.,Wigg, Andrew M.,Zhou, Siyuan
, p. 4121 - 4124 (2007/10/03)
To improve the pharmacokinetics of a previously reported series of dipeptidyl nitrile cathepsin B inhibitors, the P2-P3 amide group was replaced with an arylamine. Further optimization of this template resulted in highly potent and s